Literature DB >> 27617150

Neurofibromatosis: A Review of NF1, NF2, and Schwannomatosis.

Jesse Lee Kresak1, Meggen Walsh1.   

Abstract

The neurofibromatoses are a heterogeneous group of hereditary cancer syndromes that lead to tumors of the central and peripheral nervous systems, as well as other organ systems. By far the most common form is neurofibromatosis 1 (96%), followed by neurofibromatosis 2 (3%), and a more recently recognized, lesser known form, schwannomatosis. The diagnostic criteria, pathogenesis, molecular considerations, and clinical manifestations are discussed in this review article.

Entities:  

Keywords:  NF1; NF2; neurofibromatosis; schwannomatosis; von Recklinghausen disease

Year:  2016        PMID: 27617150      PMCID: PMC4918700          DOI: 10.1055/s-0036-1579766

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  40 in total

1.  Long-term follow-up in treatment of solar lentigo and café-au-lait macules with Q-switched ruby laser.

Authors:  T Shimbashi; R Kamide; T Hashimoto
Journal:  Aesthetic Plast Surg       Date:  1997 Nov-Dec       Impact factor: 2.326

2.  Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients.

Authors:  Scott R Plotkin; Caroline C O'Donnell; William T Curry; Catherine M Bove; Mia MacCollin; Fabio P Nunes
Journal:  J Neurosurg Spine       Date:  2011-02-04

Review 3.  Neurofibromatosis 1.

Authors:  Rosalie E Ferner
Journal:  Eur J Hum Genet       Date:  2006-09-06       Impact factor: 4.246

4.  A history of von Recklinghausen's NF1.

Authors:  Stephanie Brosius
Journal:  J Hist Neurosci       Date:  2010-10       Impact factor: 0.529

5.  Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification.

Authors:  D Gareth R Evans; R T Ramsden; A Shenton; C Gokhale; N L Bowers; S M Huson; G Pichert; A Wallace
Journal:  J Med Genet       Date:  2007-02-16       Impact factor: 6.318

6.  Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.

Authors:  Kent A Robertson; Grzegorz Nalepa; Feng-Chun Yang; Daniel C Bowers; Chang Y Ho; Gary D Hutchins; James M Croop; Terry A Vik; Scott C Denne; Luis F Parada; Cynthia M Hingtgen; Laurence E Walsh; Menggang Yu; Kamnesh R Pradhan; Mary K Edwards-Brown; Mervyn D Cohen; James W Fletcher; Jeffrey B Travers; Karl W Staser; Melissa W Lee; Marcie R Sherman; Cynthia J Davis; Lucy C Miller; David A Ingram; D Wade Clapp
Journal:  Lancet Oncol       Date:  2012-10-23       Impact factor: 41.316

7.  A clinical study of type 2 neurofibromatosis.

Authors:  D G Evans; S M Huson; D Donnai; W Neary; V Blair; V Newton; R Harris
Journal:  Q J Med       Date:  1992-08

8.  Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1).

Authors:  T Tucker; C Schnabel; M Hartmann; R E Friedrich; I Frieling; H-P Kruse; V-F Mautner; J M Friedman
Journal:  J Med Genet       Date:  2008-12-09       Impact factor: 6.318

9.  Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up.

Authors:  Brian A Neff; R Mark Wiet; John M Lasak; Noel L Cohen; Harold C Pillsbury; Richard T Ramsden; D Bradley Welling
Journal:  Laryngoscope       Date:  2007-06       Impact factor: 3.325

Review 10.  Neurofibromatosis type 1 revisited.

Authors:  Virginia C Williams; John Lucas; Michael A Babcock; David H Gutmann; Bruce Korf; Bernard L Maria
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

View more
  36 in total

1.  Ossifying Fibroma of Maxilla in a Female Affected by Neurofibromatosis Type 1.

Authors:  Shoeb Kasim Jendi; Shuaib Khatib; Jagruti Mistry; Ashwin Wagh; Kedar Vaidya; Gauri Kokane
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-09-10

2.  Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.

Authors:  J Uthoff; F A De Stefano; K Panzer; B W Darbro; T S Sato; R Khanna; D E Quelle; D K Meyerholz; J Weimer; J C Sieren
Journal:  J Neuroradiol       Date:  2018-06-27       Impact factor: 3.447

3.  Successful surgical treatment of massive spontaneous hemothorax due to intrathoracic secondary degeneration of a neurofibroma from mediastinal involvement of type 1 neurofibromatosis.

Authors:  Seong Cheol Jeong; Jae Jun Kim; Si Young Choi; Yong Hwan Kim; In Sub Kim
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

4.  Health Survey of Adults with Neurofibromatosis 1 Compared to Population Study Controls.

Authors:  Krister W Fjermestad; Livø Nyhus; Øivind J Kanavin; Arvid Heiberg; Lise B Hoxmark
Journal:  J Genet Couns       Date:  2018-02-10       Impact factor: 2.537

5.  Secondary aneurysmal bone cyst in McCune-Albright syndrome.

Authors:  Symeon Tournis; Alexia Balanika; Panayiotis D Megaloikonomos; Andreas F Mavrogenis
Journal:  Clin Cases Miner Bone Metab       Date:  2017-12-27

Review 6.  CNS Tumors in Neurofibromatosis.

Authors:  Jian Campian; David H Gutmann
Journal:  J Clin Oncol       Date:  2017-06-22       Impact factor: 44.544

7.  Clinical Reasoning: A common cause for Phelan-McDermid syndrome and neurofibromatosis type 2: One ring to bind them.

Authors:  Ariel M Lyons-Warren; Sau Wai Cheung; J Lloyd Holder
Journal:  Neurology       Date:  2017-10-24       Impact factor: 9.910

Review 8.  The Hippo Signaling Pathway in Development and Disease.

Authors:  Yonggang Zheng; Duojia Pan
Journal:  Dev Cell       Date:  2019-08-05       Impact factor: 12.270

9.  ADRENAL MICROCYSTIC RETICULAR SCHWANNOMA.

Authors:  Joana M Maciel; Daniela V Pereira; Helder F Simões; Valeriano A Leite
Journal:  AACE Clin Case Rep       Date:  2019-03-13

Review 10.  The Neurofibromatoses.

Authors:  Said Farschtschi; Victor-Felix Mautner; Anna Cecilia Lawson McLean; Alexander Schulz; Reinhard E Friedrich; Steffen K Rosahl
Journal:  Dtsch Arztebl Int       Date:  2020-05-15       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.